Xiamen Amoytop Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	1,031	827.6	555.45	287.02	181.2
Depreciation & Amortization	122.24	75.36	58.69	48.07	43.15
Other Amortization	23.9	18.08	9.53	2.3	1.18
Loss (Gain) From Sale of Assets	0.99	0.03	0.87	-0.03	1.8
Asset Writedown & Restructuring Costs	-	-	12.76	-	-
Loss (Gain) From Sale of Investments	-9.79	-4.94	-6.2	-3.92	-6.78
Provision & Write-off of Bad Debts	-0.05	3.72	0.35	-1.41	-2.34
Other Operating Activities	1.82	0.48	1.72	0.59	1.58
Change in Accounts Receivable	-405.58	-404.83	-205.76	-15.51	-24.54
Change in Inventory	-164.06	-76.53	-57.29	-13.24	-16.87
Change in Accounts Payable	88.48	0.45	153.19	61.89	63.92
Change in Other Net Operating Assets	61.86	16.1	-	-	-
Operating Cash Flow	729.38	430.63	512.1	363.16	234.78
Operating Cash Flow Growth	69.37%	-15.91%	41.01%	54.68%	153.52%
Capital Expenditures	-256.14	-251.35	-288.46	-219.17	-190.93
Sale of Property, Plant & Equipment	0.75	0.03	0.04	0.11	0.34
Cash Acquisitions	-58.39	-	-	-	-
Investment in Securities	-186.54	-57.29	-17.35	-70.34	78.66
Other Investing Activities	-	-	-	-	0.09
Investing Cash Flow	-500.33	-308.62	-305.76	-289.4	-111.84
Short-Term Debt Issued	-	-	-	-	10
Long-Term Debt Issued	140.67	-	-	-	-
Total Debt Issued	140.67	-	-	-	10
Short-Term Debt Repaid	-	-	-	-10	-18.92
Long-Term Debt Repaid	-9.39	-6.23	-6.26	-7.69	-4.61
Total Debt Repaid	-9.39	-6.23	-6.26	-17.69	-23.53
Net Debt Issued (Repaid)	131.28	-6.23	-6.26	-17.69	-13.53
Issuance of Common Stock	54.44	-	-	-	-
Common Dividends Paid	-252.87	-166.79	-86.65	-40.68	-20.68
Financing Cash Flow	-67.16	-173.02	-92.91	-58.37	-34.2
Foreign Exchange Rate Adjustments	-0.55	-0.13	-1.11	0.03	-0.49
Net Cash Flow	161.34	-51.14	112.32	15.42	88.25
Free Cash Flow	473.23	179.28	223.64	143.99	43.85
Free Cash Flow Growth	163.96%	-19.84%	55.31%	228.34%	-
Free Cash Flow Margin	12.80%	6.36%	10.65%	9.43%	3.87%
Free Cash Flow Per Share	1.16	0.44	0.55	0.36	0.11
Cash Income Tax Paid	262.66	228.82	168.12	112.85	71.33
Levered Free Cash Flow	390.68	-44.25	41.08	127.17	11.47
Unlevered Free Cash Flow	391.57	-43.96	41.4	127.56	12.14
Change in Working Capital	-440.97	-489.7	-121.08	30.53	14.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.